Difference between revisions of "Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5 (Q9396)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Ishigaki K, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: PubMed ID (P140): 12107263, #quickstatements; #temporary_batch_1590001671040) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 12107263 / rank | |||
| + | Normal rank | ||
Revision as of 19:10, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ishigaki K
0 references
